Psychiatry medmal cases concentrate around suicide-risk assessment failures, Tarasoff duty-to-warn failures, and medication-monitoring gaps (clozapine ANC, lithium toxicity, SSRI black-box in adolescents). The C-SSRS, SAFE-T, Joint Commission Sentinel Event Alert 56, Clozapine REMS, and jurisdiction-specific Tarasoff statutes define the floors. Cross-exam locks the witness into the documented structured assessment — or its absence.
Try the 2-min Psychiatry demo → All specialtiesPsychiatry cases are where "clinical judgment" defenses collapse hardest. Joint Commission Sentinel Event Alert 56 explicitly recommends structured suicide-risk assessment using validated instruments. The C-SSRS, Stanley-Brown safety plan, Clozapine REMS schedule, and lithium-monitoring intervals are either in the chart or they aren't.
Patient with documented SI; no C-SSRS or SAFE-T documented.
Recent SI/SA discharged without Stanley-Brown safety plan, lethal-means counseling, or 7-day follow-up.
Patient identified specific target of violence; no documented warning to identifiable victim or LE per jurisdiction's statute.
Clozapine patient without documented weekly ANC for first 6 months per REMS; agranulocytosis.
Lithium patient with no recent level; NSAID or ACE-inhibitor added without level check.
Patient met statutory criteria; witness allowed discharge or AMA without documented assessment of the criteria.
Physical restraint without documented least-restrictive-alternative attempt; positional asphyxia or rhabdo.
SSRI started in patient <25 without documented FDA black-box discussion with patient + parent.
Lock the witness into "I assessed her clinically — she didn't seem like a suicide risk" framing, then juxtapose against the C-SSRS / SAFE-T which the deponent admits is the validated structured instrument recommended by the Joint Commission.
Why this lands: witness has framed clinical impression as an alternative to a validated instrument the Joint Commission explicitly recommends.
Psychiatry cases are where "clinical judgment" defenses collapse hardest. The C-SSRS, SAFE-T, Stanley-Brown safety plan, Clozapine REMS, and Tarasoff jurisdictions all have published floors. Generic depo-prep AI doesn't engage that canon.
APA Practice Guidelines for Suicide-Risk Assessment, Joint Commission Sentinel Event Alert 56, Clozapine REMS Program (FDA), jurisdiction-specific Tarasoff statutes.
Yes. Expert-prep mode runs the AI as hostile plaintiff counsel against your defense psychiatrist.
Bundled in MedLegal AI Pro ($49/mo), Professional ($249/mo), or Firm ($499/mo). Free 14-day trial, no credit card.
No signup, no mic. Cross-exam architecture transfers to psychiatry — lock witness into the C-SSRS or REMS protocol, walk the chart.
Run the 2-min demo → Start free 14-day trial